Author:
Bossis Ioannis,Stratakis Constantine A.
Abstract
AbstractThe type 1α regulatory subunit (RIα) of cAMP-dependent protein kinase (PKA) (coded by the PRKAR1A gene) is the main component of type I PKA, which regulates most of the serine-threonine kinase activity catalyzed by the PKA holoenzyme in response to cAMP. Carney complex (CNC), or the complex of spotty skin pigmentation, myxomas, and endocrine overactivity, is a multiple endocrine (and not only) neoplasia syndrome that is due to PRKAR1A-inactivating mutations. The R1α protein and PRKAR1A mRNA have been found to be up-regulated in a series of cell lines and human and rodent neoplasms, suggesting this molecule’s involvement in tumorigenesis and its potential role in cell cycle regulation, growth, and/or proliferation. Alterations in PKA activity elicit a variety of effects depending on the tissue, developmental stage, degree of differentiation, and cAMP levels. In addition, RIα may have functions independent of PKA. The presence of inactivating germline mutations and the loss of its wild-type allele in some CNC lesions indicate that PRKAR1A might function as a tumor suppressor gene in these tissues, but could PRKAR1A be a classic tumor suppressor gene? Probably not, and this review explains why.
Reference98 articles.
1. Cyclic nucleotide-dependent protein kinases.;Scott;Pharmacol Ther,1991
2. cAMP-dependent protein kinase: role in normal and malignant growth.;Cho-Chung;Crit Rev Oncol Hematol,1995
3. Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action.;Francis;Crit Rev Clin Lab Sci,1999
4. Protein phosphorylation and signal transduction.;Graves;Pharmacol Ther,1999
5. Specificity in the cAMP/PKA signaling pathway;Skalhegg;Differential expression, regulation, and subcellular localization of subunits of PKA. Front Biosci,2000
Cited by
176 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献